2019 American Transplant Congress Archives

8:30am-8:45am: Role of Innate Allorecognition Pathways in Mouse Renal Allograft Rejection

D. Zhao¹, H. Dai¹, K. Abou-Daya¹, A. Williams¹, M. Oberbarnscheidt¹, X. Li², F. Lakkis¹

Plenary Session I • Veterans Auditorium

8:45am-9:00am: Oxygenated Hypothermic Machine Perfusion of Kidneys Donated after Circulatory Death: An International Randomised Controlled Trial

I. Jochmans¹, H. S. Hofker², L. Davies³, S. Knight³, J. Pirenne¹, R. J. Ploeg³, -. on behalf of COPE and participating centres⁴

Plenary Session I • Veterans Auditorium

9:00am-9:15am: Discovery and Validation of an Early Post-Transplant Biomarker Model Predictive of Chronic Kidney Disease in Liver Transplant Recipients

J. Levitsky¹, S. Asrani², G. Klintmalm², T. Schiano², A. Moss³, K. Chavin⁴, C. Miller⁵, L. Zhao⁶, K. Guo⁶, N. Bridges⁷, J. Odim⁷, M. Brown⁷, D. Ikle⁸, B. Armstrong⁸, M. Abecassis⁹

Plenary Session I • Veterans Auditorium

9:15am-9:30am: Bcl-2 Inhibition with Venetoclax Promotes Induction of Mixed Chimerism and Renal Allograft Tolerance without Severe Myelosuppression in Non-Human Primate

H. Sasaki¹, D. Ma¹, T. Oura¹, A. Dehnadi¹, I. Rosales², B. Cosimi¹, P. Cippa³, T. Fehr³, T. Kawai¹

Plenary Session I • Veterans Auditorium

2:30pm-2:42pm: An 8-Gene Expression Assay in Peripheral Blood for Diagnosis of Antibody-Mediated Rejection after Kidney Transplantation

E. Van Loon¹, S. Gazut², S. Yazdani¹, E. Lerut¹, H. de Loor¹, M. Coemans¹, L. Noël³, L. Thorrez¹, L. Van Lommel¹, F. Schuit¹, D. Lambrechts¹, T. Van Brussel¹, B. Sprangers¹, D. Kuypers¹, M. Essig⁴, W. Gwinner⁵, D. Anglicheau⁶, P. Marquet⁷, M. Naesens¹

Concurrent Session: Biomarkers, Immune Monitoring and Outcomes I • Room 306

2:30pm-2:42pm: Costimulation Blockade Modulates Humoral Responses in Highly Sensitized Transplant Recipients

J. Kwun, B. Ezekian, P. Schroder, M. Manook, J. Yoon, M. Mulvihill, K. Freischlag, J. Yi, S. Knechtle

Concurrent Session: Kidney Immunosuppression: Desensitization • Ballroom A

2:30pm-2:42pm: Early Use of Everolimus Plus Reduced Tacrolimus vs Standard Tacrolimus in De Novo Livertransplant Recipients: 12 Months Efficacy and Safety Data from HEPHAISTOS Study

B. Nashan¹, P. Schemmer¹, H. Schlitt¹, A. Pascher¹, C. Klein¹, U. Neumann¹, I. Kroeger², P. Wimmer², F. Braun¹

Concurrent Session: Liver: Immunosuppression and Rejection • Room 312

2:30pm-2:42pm: Endothelial Cell Replacement – A Closer Step to Personalized, Tissue-Engineered Transplants

S. Cohen, S. Partouche, M. Gurevich, V. Mezhybovsky, V. Tennak, S. Eisner, E. Nesher, E. Mor

Concurrent Session: Tissue Engineering & Technology • Room 309

2:30pm-2:42pm: Impact of Glomerulitis at 4-Month Biopsy on Long Term Kidney Allograft Outcomes

M. Whigham, G. Mour, M. Buras, S. Sukumaran Nair, A. Jaramillo, D. Ramon, R. Heilman

Concurrent Session: Kidney Complications: Late Graft Failure I • Veterans Auditorium

2:30pm-2:42pm: Impact of Immunosuppressive Drug Withdrawal on Persistent Mixed Chimerism in Recipients of HLA Haplo-Identical Kidney and Hematopoietic Cell Transplants

S. Busque, J. Scandling, R. Lowsky, J. Shizuru, E. Meyer, K. Jensen, A. Shori, R. Hoppe, E. Engleman, S. Strober

Concurrent Session: Tolerance: Clinical Studies • Room 208